Drug Shortage Report for FENTORA
Report ID | 246115 |
Drug Identification Number | 02408023 |
Brand name | FENTORA |
Common or Proper name | FENTORA 400MCG BUCCAL TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | FENTANYL |
Strength(s) | 400MCG |
Dosage form(s) | TABLET (EFFERVESCENT) |
Route of administration | SUBLINGUAL BUCCAL SUBLINGUAL BUCCAL |
Packaging size | PP28 |
ATC code | N02AB |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-12-18 |
Estimated end date | 2025-02-07 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-02-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2025-02-03 | French | Compare |
v5 | 2025-02-03 | English | Compare |
v4 | 2025-01-30 | French | Compare |
v3 | 2025-01-30 | English | Compare |
v2 | 2024-12-19 | French | Compare |
v1 | 2024-12-19 | English | Compare |
Showing 1 to 6 of 6